Ownership history in Intellectus Partners, LLC · 20 quarters on record
This page tracks every 13F SEC filing in which Intellectus Partners, LLC reported a position in Abcellera Biologics (ABCL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 523,383 | -19,750 | -3.6% | 0.35% | $1.8M | $3.42 |
| 2025 Q3 | REDUCED | 543,133 | -5,000 | -0.9% | 0.53% | $2.7M | $5.03 |
| 2025 Q2 | UNCHANGED | 548,133 | — | 0% | 0.41% | $1.9M | $3.43 |
| 2025 Q1 | ADDED | 548,133 | +600 | +0.1% | 0.30% | $1.2M | $2.23 |
| 2024 Q4 | ADDED | 547,533 | +2,000 | +0.4% | 0.36% | $1.6M | $2.93 |
| 2024 Q3 | UNCHANGED | 545,533 | — | 0% | 0.36% | $1.4M | $2.60 |
| 2024 Q2 | ADDED | 545,533 | +3,750 | +0.7% | 0.44% | $1.6M | $2.96 |
| 2024 Q1 | REDUCED | 541,783 | -345,500 | -38.9% | 0.65% | $2.5M | $4.53 |
| 2023 Q4 | ADDED | 887,283 | +10,650 | +1.2% | 1.46% | $5.1M | $5.71 |
| 2023 Q3 | REDUCED | 876,633 | -800 | -0.1% | 1.28% | $4.0M | $4.60 |
As of 2025 Q4 — sorted by position size